More Stories
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.
Chinese stocks could surge higher as investors get ‘FOMO,’ Goldman Sachs says
International investors are getting increasingly concerned about missing out on the rally that was sparked by the unveiling of the...
Satellite-TV rivals DirecTV, Dish reportedly in advanced merger talks
The Wall Street Journal reported DirecTV could acquire rival Dish, creating one of the nation’s largest pay-TV providers, in a...
China ETFs set for best week on record after Beijing fires policy ‘bazooka’ to boost economy. Is it time to jump in?
China ETFs have surged on the back of a blitz of stimulus measures by the country’s government to revive the...
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S....
This company had $1 billion in quarterly AI bookings — and it’s not a chip maker
Accenture’s stock rallied toward a six-month high Thursday, after the management consultant got back to beating earnings expectations and continued...